Dosimetric Modeling of Lymphopenia in Patients With Metastatic Cancer Receiving Palliative Radiation and PD-1 Immune Checkpoint Inhibitors by Jack M. Qian, MD, Elliot Akama-Garren, MS, Jungwook Shin, PhD, Lauren Gunasti, BA, Andrew Bang, MD, Luke R.G. Pike, MD, DPhil, Clemens Grassberger, PhD, Jonathan D. Schoenfeld, MD, MPH

Get full text

Intracranial Outcomes of De Novo Brain Metastases Treated With Osimertinib Alone in Patients With Newly Diagnosed EGFR-Mutant NSCLC by Brandon S. Imber, MD, MA, Ryka Sehgal, MD, Rachel Saganty, MD, Anne S. Reiner, MPH, A. Turan Ilica, MD, Emily Miao, PharmD, Bob T. Li, MD, Gregory J. Riely, MD, Helena A. Yu, MD, Katherine S. Panageas, DrPH, Robert J. Young, MD, Luke R.G. Pike, MD, DPhil, Nelson S. Moss, MD

Get full text

Local Therapy for Isolated Central Nervous System Progression Among Patients Receiving Antibody-Drug Conjugate Therapy by Emily S. Lebow, MD, Jordan Eichholz, MS, Zhigang Zhang, PhD, Nicolas Toumbacaris, MSPH, Brandon Imber, MD, MA, Linda Chen, MD, Quincey LaPlant, MD, PhD, Josh Yamada, MD, Luke R.G. Pike, MD, DPhil, Shanu Modi, MD, Andrew D. Seidman, MD, Kathryn Beal, MD, Nelson S. Moss, MD, Yao Yu, MD

Get full text